D2 Pharma Consulting, LLC

Corporate Name

D2 Pharma Consulting, LLC

Corporate Ownership

Private Company

Head Office Address

Home office: 6209 Mid Rivers Mall Drive, Suite 125, Saint Charles, MO 63304, USA

Facilities City & Country

Saint Charles, MO 63376, USA

Web-site Address

www.d2rx.com

No. of Employees

30

Contact

(Korean Business)

Name

Dean P. Erhardt, MBA

Address

6209 Mid Rivers Mall Drive, Suite 125, Saint Charles, MO 63304, U.S.A.

Telephone

314-308-2028

E-mail

Dean.Erhardt@d2rx.com

Company History

D2 Pharma Consulting LLC is an independent consulting firm founded by two partners with deep experience in the healthcare sector, including all aspects of commercialization/distribution and a broad scope of business development expertise. Their goal was to bring together industry experts with a proven track record of real world experience to build a truly best-in-class consulting firm focused on providing cost effective, outsourced solutions.

The D2 team of professionals brings decades of experience from the top tier organizations in Healthcare Distribution, PBM, Biopharma and Specialty Pharmacy. Each member of the D2 team brings a varying scope of expertise that in combination creates a powerful force providing excellence and value to D2 clients.The D2 team provides over 400+ years of industry experience.

In addition, D2 is a member of several key industry organizations, including the National Association of Boards of Pharmacy (NACDS), Healthcare Distribution Management Organization (HDMA), Regulatory Harmonization Institute (RHI) and GS1 US. D2 team members serve on various boards and committees including Pharmacist Letter- Advisory Board, National Council of Prescription Drugs Programs (NCPDP), Texas Pharmacists Association, Bio DFW, Industry Board NACDS, RHI and GS1 EPCIS Subcommittee.

Company Description & Organization

D2 Pharma Consulting LLC (D2) is a best-in-class consulting company exclusively focused on serving the life sciences industry.D2 assists emerging and established pharmaceutical, biopharmaceutical and medical device manufacturers to develop and execute strategicinitiatives, ensuring successful launch, distribution and reimbursement to support an ongoing leadership position in the marketplace. D2’s reach includes the US, Canada, Puerto Rico and over 20 European markets.

Corporate Main

Service Area

Contract Research

& Development

Contract

Manufacturing

Contract Sales &

Marketing

Consulting

○

○

○

Geographical

Business Area

Contract Research

& Development

Contract

Manufacturing

Contract Sales &

Marketing

Consulting

US

○

US

○

US

○

US

○

Canada

Canada

Canada

○

Canada

○

EU

EU

EU

○

EU

○

Asia

Asia

Asia

Asia

○

Global

Global

Global

Global

○

Other

Other

Other

Other

Focusing Contract

Service Area

Contract Research

& Development

Contract

Manufacturing

Contract Sales &

Marketing

Consulting

Research

API

APIs

○

R&D

Pre-Clinical

R&D Strategy

& Management

Pre-clinical

Test Sample

○

Phase I

Clinical Trials

Phase II

Clinical Test

Sample

○

Finished

Products

Regulatory

Affairs

Phase III

Business

Development

○

Finished

Product

○

Phase IV

Sales &

Marketing

○

Corporate Product Area

New Drug

Biologics

Herbal

Medicine

Biosimilars

NCE

NME

○

Generics

APIs

Devices

Others

○

○

Clients' Composition

(%)

Big Pharmas

Mid or Small

-Size Pharmas

Biotech

Companies

Start-ups

10%

20%

35%

35%

In-house Facilities

Research &

Development

Preclinical

Clinical

Custom

Manufacturing

Custom Sales

○

○

Focusing Therapeutic Area

D2 has 3 pharmacists on the team and has worked across all therapeutic areas.  In addition D2 focuses on specialty therapies including but not limited to:

- Growth hormone disorders

- IVIg/ SCIg

- Diabetes

- Hepatitis C

- Multiple Sclerosis (injectable and oral)

- Psoriasis

- Rheumatoid arthritis/Crohn’s Disease

- Hemophilia factor

- Oncology (oral and injectable)

- Human Growth Hormone

- Hereditary Angioedema

Alpha1 Anti-trypsin Disease

General Overview

of Corporate's Key

Contract Services

D2 Pharma Consulting - Core Services

D2’s approach enables cost effective commercialization for both emerging and established organizations. Our outsourced support model enables companies to access key relationships and market expertise. Our clients include US and international pharmaceutical, biotech and device companies.

Contract Service Capacity Affordable by Service Area

D2 Pharma Consulting LLC (D2) works with our clientsto develop a detailed, customized outline of the deliverables required to implement their Statements of Work.  D2 identifies timelines that, when put into action, will ensure the successful trade launch of products brought to market by member companies. 

Key components of the deliverables outlined include, but are not limited to:

- Strategic Planning 

- Managed Care Services

- Logistics Planning and Contracting

- State Licensing

- Order to Cash (3PL) Strategy and Pricing

- Develop Trade Customer Relationships and Establish Trade Agreements

- Ongoing Trade

- Ongoing Trade Group Purchasing Organizational Management

Communication with Clients

Dispositoion of

Project Manager

Responsible

All of D2’s project managers have no less than 20 years industry experience in the areas of service for our clients.

Providing Realtime

Service Delivery

Our consultants are available to our clients 24/7 and are connected through mobile services as needed.

Realtime

Feed-back

We provide continuous feedback to our clients in real time and are completely accessible at both the account manager and the Senior executive level.We meet needed deadlines. We work out a schedule which meets the needs of the client.

Corporate

Competitiveness

All of our consultants are world class experts in their area of service to our clients.  The pricing of our services are flexible with a potential combination of retainer, hourly, project based or equity.  D2’s area of specialization includes:

Countries which

clients belong to

USA, Canada, EU and Korea

Asian Clients'

Composition(%)

Big Pharmas

Mid or Small

-Size Pharmas

Biotech

Companies

Start-ups

50%

50%

No. of Asian Clients

in recent 3 years

7

Major Service Range

with Asian Companies

Contract Research

& Development

Contract

Manufacturing

Contract Sales &

Marketing

Consulting

Research

API

APIs

R&D

Pre-Clinical

R&D Strategy

& Management

Pre-clinical

Test Sample

Phase I

Clinical Trials

Phase II

Clinical Test

Sample

Finished

Products

Regulatory

Affairs

Phase III

Business

Development

○

Finished

Product

Phase IV

Sales &

Marketing

○

D2 has both the capabilities as well as the relationships to support Korean companies in commercializing products in the US, Canada, Puerto Rico and over 20 other European countries.  In addition, Dean Erhardt, D2 Principal is the President of the Regulatory Consulting Institute whose members can provide every aspect of bringing products to market from API access and Clinical trial design through to patient access to medications. D2’s team touches every commercial aspect of launching in the US market and can provide the relationships and contacts to support cost effective support to Korean pharmaceutical companies. Finally D2’s relationships can also support the identification of funding, manufacturing and marketing partners to develop success across the pharmaceutical, biotech and medical device markets.